Drug Shortage Report for TEVA-GLICLAZIDE
Report ID | 88164 |
Drug Identification Number | 02238103 |
Brand name | TEVA-GLICLAZIDE |
Common or Proper name | GLICLAZIDE |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | GLICLAZIDE |
Strength(s) | 80MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 & 500 |
ATC code | A10BB |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | |
Actual start date | 2019-07-02 |
Estimated end date | 2020-07-31 |
Actual end date | 2020-07-22 |
Shortage status | Resolved |
Updated date | 2020-07-23 |
Company comments | Delays getting API for next lots. Allocating to 100% of our market. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v47 | 2020-07-23 | French | Compare |
v46 | 2020-07-23 | English | Compare |
v45 | 2020-07-09 | French | Compare |
v44 | 2020-07-09 | English | Compare |
v43 | 2020-07-09 | French | Compare |
v42 | 2020-07-09 | English | Compare |
v41 | 2020-06-25 | French | Compare |
v40 | 2020-06-25 | English | Compare |
v39 | 2020-06-04 | French | Compare |
v38 | 2020-06-04 | English | Compare |
v37 | 2020-05-21 | French | Compare |
v36 | 2020-05-21 | English | Compare |
v35 | 2020-05-21 | French | Compare |
v34 | 2020-05-21 | English | Compare |
v33 | 2020-05-08 | French | Compare |
v32 | 2020-05-08 | English | Compare |
v31 | 2020-05-01 | French | Compare |
v30 | 2020-05-01 | English | Compare |
v29 | 2020-04-23 | French | Compare |
v28 | 2020-04-23 | English | Compare |